Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

N-acetylcysteine amide (AD4) reduces cocaine-induced reinstatement.

Jastrzębska J, Frankowska M, Filip M, Atlas D.

Psychopharmacology (Berl). 2016 Sep;233(18):3437-48. doi: 10.1007/s00213-016-4388-5. Epub 2016 Jul 28.

PMID:
27469021
2.

Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Graziani M, Antonilli L, Togna AR, Grassi MC, Badiani A, Saso L.

Oxid Med Cell Longev. 2016;2016:8408479. doi: 10.1155/2016/8408479. Epub 2015 Dec 28. Review.

3.

N-acetylcysteine Facilitates Self-Imposed Abstinence After Escalation of Cocaine Intake.

Ducret E, Puaud M, Lacoste J, Belin-Rauscent A, Fouyssac M, Dugast E, Murray JE, Everitt BJ, Houeto JL, Belin D.

Biol Psychiatry. 2016 Aug 1;80(3):226-34. doi: 10.1016/j.biopsych.2015.09.019. Epub 2015 Oct 8.

4.

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.

Roberts-Wolfe DJ, Kalivas PW.

CNS Neurol Disord Drug Targets. 2015;14(6):745-56. Review.

5.

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R.

Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Review.

6.

Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking.

Weiland A, Garcia S, Knackstedt LA.

Front Pharmacol. 2015 Mar 10;6:44. doi: 10.3389/fphar.2015.00044. eCollection 2015.

7.

N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats.

Schneider R Jr, Santos CF, Clarimundo V, Dalmaz C, Elisabetsky E, Gomez R.

Alcohol. 2015 May;49(3):259-63. doi: 10.1016/j.alcohol.2015.01.009. Epub 2015 Feb 13.

PMID:
25771148
8.

N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration.

Winefield RD, Heemskerk AA, Kaul S, Williams TD, Caspers MJ, Prisinzano TE, McCance-Katz EF, Lunte CE, Faiman MD.

J Pharm Biomed Anal. 2015 Mar 25;107:518-25. doi: 10.1016/j.jpba.2015.01.036. Epub 2015 Jan 25.

9.

N-acetyl cysteine mitigates the acute effects of cocaine-induced toxicity in astroglia-like cells.

Badisa RB, Kumar SS, Mazzio E, Haughbrook RD, Allen JR, Davidson MW, Fitch-Pye CA, Goodman CB.

PLoS One. 2015 Jan 24;10(1):e0114285. doi: 10.1371/journal.pone.0114285. eCollection 2015.

10.

The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.

Mousavi SG, Sharbafchi MR, Salehi M, Peykanpour M, Karimian Sichani N, Maracy M.

Arch Iran Med. 2015 Jan;18(1):28-33. doi: 0151801/AIM.008.

11.

Systematic review of N-acetylcysteine in the treatment of addictions.

Asevedo E, Mendes AC, Berk M, Brietzke E.

Rev Bras Psiquiatr. 2014 Apr-Jun;36(2):168-75. Epub 2014 Mar 17. Review.

12.

The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression.

Frankowska M, Jastrzębska J, Nowak E, Białko M, Przegaliński E, Filip M.

Behav Brain Res. 2014 Jun 1;266:108-18. doi: 10.1016/j.bbr.2014.02.044. Epub 2014 Mar 5.

PMID:
24613240
13.

Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement.

Reissner KJ, Gipson CD, Tran PK, Knackstedt LA, Scofield MD, Kalivas PW.

Addict Biol. 2015 Mar;20(2):316-23. doi: 10.1111/adb.12127. Epub 2014 Feb 25.

14.

Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine.

Corbit LH, Chieng BC, Balleine BW.

Neuropsychopharmacology. 2014 Jul;39(8):1893-901. doi: 10.1038/npp.2014.37. Epub 2014 Feb 17.

15.

Potential role of N-acetylcysteine in the management of substance use disorders.

McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM.

CNS Drugs. 2014 Feb;28(2):95-106. doi: 10.1007/s40263-014-0142-x. Review.

16.

Cocaine-induced agitated delirium: a case report and review.

Plush T, Shakespeare W, Jacobs D, Ladi L, Sethi S, Gasperino J.

J Intensive Care Med. 2015 Jan;30(1):49-57. doi: 10.1177/0885066613507420. Epub 2013 Nov 7. Review.

PMID:
24212597
17.

Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.

Schneider KJ, DeCaprio AP.

Chem Res Toxicol. 2013 Nov 18;26(11):1755-64. doi: 10.1021/tx4003116. Epub 2013 Oct 30.

PMID:
24112049
18.

Role of nucleus accumbens glutamatergic plasticity in drug addiction.

Quintero GC.

Neuropsychiatr Dis Treat. 2013;9:1499-512. doi: 10.2147/NDT.S45963. Epub 2013 Sep 30. Review.

19.

Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism.

Reissner KJ, Brown RM, Spencer S, Tran PK, Thomas CA, Kalivas PW.

Neuropsychopharmacology. 2014 Jan;39(2):499-506. doi: 10.1038/npp.2013.223. Epub 2013 Aug 29.

20.

A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.

LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ.

Am J Addict. 2013 Sep-Oct;22(5):443-52. doi: 10.1111/j.1521-0391.2013.12034.x. Epub 2013 May 15.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk